Idenix Pharmaceuticals News
Most Popular Idenix Pharmaceuticals Story
GSK licenses Idenix HIV drug for $450M
GSK has inked a $450 million deal for Idenix Pharmaceutical's experimental HIV/AIDS drug, IDX899. Idenix gets a $34 million up-front payment; half was cash and the rest came from a purchase of Idenix... Read more...
Latest Headlines
- October 30, 2009
- October 5, 2009
- February 6, 2009
- February 7, 2008
- September 28, 2007
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
